Microbial Therapeutic Products Market - Global Industry Analysis

Microbial Therapeutic Products Market

Global Microbial Therapeutic Products Market By Product (GCSF, Peg GCSF, Exenatide, Anti-cancer Agents, Immunosuppressants, Enzymes, and Others), By Route of Administration (Single-use Pre-filled Injection/Injector Pens, Multi-use Injectors, and Others), By Source (Bacteria, and Fungi), By Application (Metabolic Disorders, Hematological Disorders, Oncology, Immunological Disorders, Infectious Diseases, Allergic Diseases, and Others), By End-user (Hospitals, Pharmaceuticals & Biopharmaceutical Companies, and Research & Academic Institutions), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028

Published Date: 23-Aug-2022 Category: Healthcare Report Format : PDF Pages: 277 Report Code: ZMR-6181 Status : Published

The global microbial therapeutic products market size was worth USD 63,281.50 million in 2021 and is estimated to grow to about USD 95,502.24 million by 2028, with a compound annual growth rate (CAGR) of around 7.10 percent during the forecast period.

Microbial Therapeutic Products Market

Description

Microbial Therapeutic Products Market Size And Industry Analysis

The global microbial therapeutic products market size was worth USD 63,281.50 million in 2021 and is estimated to grow to USD 95,502.24 million by 2028, with a compound annual growth rate (CAGR) of approximately 7.10 percent over the forecast period. The report analyzes the microbial therapeutic products market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the microbial therapeutic products market.

Microbial Therapeutic Products Market: Overview

Microorganisms form microbial products, and the microbial manufacturing biotechnology industry is related to this area. These bacteria have been used for decades to make cheese, bread, vinegar, and wine, among many others. Medical microbiology includes enzymes, antibiotics, nutrients such as amino acids, vitamins, and organic acids, as well as vaccine production. The growing demand for healthcare nutrients such as vitamins, coupled with the increasing demand for diagnostic microbiology products, is expected to drive the market in the forecast years. At the same time, budget constraints of small and medium-sized market players hamper the market growth during the forecast period.

COVID-19 Impact:

The COVID-19 pandemic has impacted the businesses of microbial therapeutic. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the covid-19 pandemic; the global microbial therapeutic products market is likely to be impacted considerably during the forecast period. Besides that, the uncertain use of these microbial therapeutic products affected the market growth during the pandemic period.

Key Insights

  • As per the analysis shared by our research analyst, the global microbial therapeutic products market value is expected to grow at a CAGR of 7.10% over the forecast period.
  • In terms of revenue, the global microbial therapeutic products market size was valued at USD 63,281.50 million in 2021 and is estimated to grow to USD 95,502.24 million by 2028.
  • The growing demand for healthcare nutrients such as vitamins and the increasing demand for diagnostic microbiology products is expected to drive the market.
  • By application, the oncology segment accounted significant amount of market share in 2021.
  • By source, the bacteria segment dominated with accounted significant market share in 2021.
  • In 2021, North America captured the largest revenue share of the global market.

Microbial Therapeutic Products Market: Growth Drivers

The growing demand for healthcare nutrients aids the global market growth

According to analysts, the growing demand for healthcare nutrients such as vitamins and the increasing demand for diagnostic microbiology products is expected to drive the market in the forecast years. In addition, the rise of diseases such as cancer is expected to boost the industry in the coming years. Other factors expected to drive the global microbial therapeutic products market growth during the estimated period include enzyme production for end-use industries such as food preservation, leather, and paper. Several limitations and issues need to be overcome for the market to continue to grow.

Microbial Therapeutic Products Market: Restraints

The lack of accuracy may hamper the global market growth

The key restraints for the global microbial therapeutic products market are the lack of accurate information. Some aspects of specific microscopic organisms can be transferred to non-critical species, which poses a challenge in determining drug efficacy.

Microbial Therapeutic Products Market: Opportunities

The adoption of technology brings up several growth opportunities

Fermentation technology is the most widely applied method for producing microbial products that convert sugars into gases, alcohols, or acids. Increasing advances in fermentation technology can change the entire production process of microbial products. Usually, fermentation depends on using limited raw materials, and different bacterial strains have meager yields. But new recombinant technology is being used to manipulate the structure of microorganisms to increase their efficiency and make them capable of using various raw materials. Furthermore, by using these engineered microorganisms, the production of microbial products can be achieved more naturally and economically by introducing mutations into the organism. Pl plasmids and vectors for gene amplification are one of the modern advances in biotechnology to increase bacteria's productivity.

Microbial Therapeutic Products Market: Segmentation

The global microbial therapeutic products market is segregated based on product, route of administration, source, application, end-user, and region.

By source, the market is divided into bacteria and fungi. Among these, the microbial therapies derived from bacteria are expected to remain profitable as they are widely available from various sources. In addition, microorganisms perform the function of setting events and producing medicinal drugs, including anti-infective agents and nutrients. Given their harmless nature, the stomach microbiome has been a well-known source of refined bacteria over time. Gut bacteria are very beneficial in treating digestive problems and food poisoning.

By application, the market is bifurcated into metabolic disorders, hematological disorders, oncology, immunological disorders, infectious diseases, allergic diseases, and others. Over the forecast period, oncology and metabolic disorders are expected to account for a significant share of the global market. As indicated by research, Bacteriocin’s anti-infectives, chemicals, and peptides have great potential to provide drugs against malignant growth. Oncology seems to be the most promising candidate for future drug development.

Recent Developments

  • November 2020 – Dr. Reddy’s Laboratory has announced a definitive agreement with Glenmark Pharmaceuticals Ltd. Acquired the anti-allergy brands Momat Rino, Momat Rino Advance, and Momat A to market them in Russia, Kazakhstan, and Uzbekistan, respectively.
  • December 2020 – Novo Nordisk has announced the acquisition of Emisphere Technologies to exercise ownership of its Eligen SNAC oral delivery technology. The acquisition will accelerate the production of the GLP-1 receptor agonist, liraglutide, on a larger scale.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Microbial Therapeutic Products Market: Regional Landscape

The presence of market players and advancements help North America dominate the global market

North America is expected to be the dominant region in the global microbial therapeutic products market during the forecast period due to technological advances and increased industry research and development investment. Each year, the personal care industry in the United States reaches an increasingly high level of development. Women nationwide use 12 unique care products daily, while men use an average of six products daily. With more independent companies with shorter supply chains and greater resonance with younger customers, consumer spending has shifted primarily to skin care. Cosmetics are an essential component of the personal care business in the country, and some larger companies are having trouble complying with the definition of probiotics as living organisms in molded microbiological products.

Microbial Therapeutic Products Market: Competitive Landscape

Some of the main competitors dominating the global microbial therapeutic products market include - Amgen Inc., F. Hoffmann La-Roche Ltd., Mylan N.V., Novartis AG, Biocon, Merck & Co. Inc., Pfizer Inc., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Bristol-Myers Squibb Company, Novo Nordisk A/S, and Abbot Laboratories.

The global microbial therapeutic products market is segmented as follows:

By Product

  • GCSF
  • Peg GCSF
  • Exenatide
  • Anti-cancer Agents
  • Immunosuppressants
  • Enzymes
  • Others

By Route of Administration

  • Single-use Pre-filled Injection/Injector Pens
  • Multi-use Injectors
  • Others

By Source

  • Bacteria
  • Fungi

By Application

  • Metabolic Disorders
  • Hematological Disorders
  • Oncology
  • Immunological Disorders
  • Infectious Diseases
  • Allergic Diseases
  • Others

By End-user

  • Hospitals
  • Pharmaceuticals & Biopharmaceutical Companies
  • Research & Academic Institutions

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France 
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Microbial Therapeutic Products Market, (2022 - 2028) (USD Million)
    • 2.2 Global Microbial Therapeutic Products Market : snapshot
  • Chapter 3. Global Microbial Therapeutic Products Market - Industry Analysis
    • 3.1 Microbial Therapeutic Products Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 The growing demand for healthcare nutrients aids the global market growth
    • 3.3 Market Restraints
      • 3.3.1. The lack of accuracy may hamper the global market growth
    • 3.4 Market Opportunities
      • 3.4.1. The adoption of technology brings up several growth opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Product
      • 3.7.2 Market attractiveness analysis By Route of Administration
      • 3.7.3 Market attractiveness analysis By Source
      • 3.7.4 Market attractiveness analysis By Application
      • 3.7.5 Market attractiveness analysis By End-user
  • Chapter 4. Global Microbial Therapeutic Products Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Microbial Therapeutic Products Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Microbial Therapeutic Products Market - Product Analysis
    • 5.1 Global Microbial Therapeutic Products Market overview: By Product
      • 5.1.1 Global Microbial Therapeutic Products Market share, By Product, 2021 and 2028
    • 5.2 GCSF
      • 5.2.1 Global Microbial Therapeutic Products Market by GCSF, 2022 - 2028 (USD Million)
    • 5.3 Peg GCSF
      • 5.3.1 Global Microbial Therapeutic Products Market by Peg GCSF, 2022 - 2028 (USD Million)
    • 5.4 Exenatide
      • 5.4.1 Global Microbial Therapeutic Products Market by Exenatide, 2022 - 2028 (USD Million)
    • 5.5 Anti-cancer Agents
      • 5.5.1 Global Microbial Therapeutic Products Market by Anti-cancer Agents, 2022 - 2028 (USD Million)
    • 5.6 Immunosuppressants
      • 5.6.1 Global Microbial Therapeutic Products Market by Immunosuppressants, 2022 - 2028 (USD Million)
    • 5.7 Enzymes
      • 5.7.1 Global Microbial Therapeutic Products Market by Enzymes, 2022 - 2028 (USD Million)
    • 5.8 Others
      • 5.8.1 Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • Chapter 6. Global Microbial Therapeutic Products Market - Route of Administration Analysis
    • 6.1 Global Microbial Therapeutic Products Market overview: By Route of Administration
      • 6.1.1 Global Microbial Therapeutic Products Market share, By Route of Administration, 2021 and 2028
    • 6.2 Single-use Pre-filled Injection/Injector Pens
      • 6.2.1 Global Microbial Therapeutic Products Market by Single-use Pre-filled Injection/Injector Pens, 2022 - 2028 (USD Million)
    • 6.3 Multi-use Injectors
      • 6.3.1 Global Microbial Therapeutic Products Market by Multi-use Injectors, 2022 - 2028 (USD Million)
    • 6.4 Others
      • 6.4.1 Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • Chapter 7. Global Microbial Therapeutic Products Market - Source Analysis
    • 7.1 Global Microbial Therapeutic Products Market overview: By Source
      • 7.1.1 Global Microbial Therapeutic Products Market share, By Source, 2021 and 2028
    • 7.2 Bacteria
      • 7.2.1 Global Microbial Therapeutic Products Market by Bacteria, 2022 - 2028 (USD Million)
    • 7.3 Fungi
      • 7.3.1 Global Microbial Therapeutic Products Market by Fungi, 2022 - 2028 (USD Million)
  • Chapter 8. Global Microbial Therapeutic Products Market - Application Analysis
    • 8.1 Global Microbial Therapeutic Products Market overview: By Application
      • 8.1.1 Global Microbial Therapeutic Products Market share, By Application, 2021 and 2028
    • 8.2 Metabolic Disorders
      • 8.2.1 Global Microbial Therapeutic Products Market by Metabolic Disorders, 2022 - 2028 (USD Million)
    • 8.3 Hematological Disorders
      • 8.3.1 Global Microbial Therapeutic Products Market by Hematological Disorders, 2022 - 2028 (USD Million)
    • 8.4 Oncology
      • 8.4.1 Global Microbial Therapeutic Products Market by Oncology, 2022 - 2028 (USD Million)
    • 8.5 Immunological Disorders
      • 8.5.1 Global Microbial Therapeutic Products Market by Immunological Disorders, 2022 - 2028 (USD Million)
    • 8.6 Infectious Diseases
      • 8.6.1 Global Microbial Therapeutic Products Market by Infectious Diseases, 2022 - 2028 (USD Million)
    • 8.7 Allergic Diseases
      • 8.7.1 Global Microbial Therapeutic Products Market by Allergic Diseases, 2022 - 2028 (USD Million)
    • 8.8 Others
      • 8.8.1 Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • Chapter 9. Global Microbial Therapeutic Products Market - End-user Analysis
    • 9.1 Global Microbial Therapeutic Products Market overview: By End-user
      • 9.1.1 Global Microbial Therapeutic Products Market share, By End-user, 2021 and 2028
    • 9.2 Hospitals
      • 9.2.1 Global Microbial Therapeutic Products Market by Hospitals, 2022 - 2028 (USD Million)
    • 9.3 Pharmaceuticals & Biopharmaceutical Companies
      • 9.3.1 Global Microbial Therapeutic Products Market by Pharmaceuticals & Biopharmaceutical Companies, 2022 - 2028 (USD Million)
    • 9.4 Research & Academic Institutions
      • 9.4.1 Global Microbial Therapeutic Products Market by Research & Academic Institutions, 2022 - 2028 (USD Million)
  • Chapter 10. Microbial Therapeutic Products Market - Regional Analysis
    • 10.1 Global Microbial Therapeutic Products Market Regional Overview
    • 10.2 Global Microbial Therapeutic Products Market Share, by Region, 2021 & 2028 (USD Million)
    • 10.3. North America
      • 10.3.1 North America Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
        • 10.3.1.1 North America Microbial Therapeutic Products Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 North America Microbial Therapeutic Products Market, by Product, 2022 - 2028
      • 10.4.1 North America Microbial Therapeutic Products Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 North America Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028
      • 10.5.1 North America Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028 (USD Million)
    • 10.6 North America Microbial Therapeutic Products Market, by Source, 2022 - 2028
      • 10.6.1 North America Microbial Therapeutic Products Market, by Source, 2022 - 2028 (USD Million)
    • 10.7 North America Microbial Therapeutic Products Market, by Application, 2022 - 2028
      • 10.7.1 North America Microbial Therapeutic Products Market, by Application, 2022 - 2028 (USD Million)
    • 10.8 North America Microbial Therapeutic Products Market, by End-user, 2022 - 2028
      • 10.8.1 North America Microbial Therapeutic Products Market, by End-user, 2022 - 2028 (USD Million)
    • 10.4. Europe
      • 10.4.2 Europe Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
        • 10.4.2.1 Europe Microbial Therapeutic Products Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Europe Microbial Therapeutic Products Market, by Product, 2022 - 2028
      • 10.4.1 Europe Microbial Therapeutic Products Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Europe Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028
      • 10.5.1 Europe Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028 (USD Million)
    • 10.6 Europe Microbial Therapeutic Products Market, by Source, 2022 - 2028
      • 10.6.1 Europe Microbial Therapeutic Products Market, by Source, 2022 - 2028 (USD Million)
    • 10.7 Europe Microbial Therapeutic Products Market, by Application, 2022 - 2028
      • 10.7.1 Europe Microbial Therapeutic Products Market, by Application, 2022 - 2028 (USD Million)
    • 10.8 Europe Microbial Therapeutic Products Market, by End-user, 2022 - 2028
      • 10.8.1 Europe Microbial Therapeutic Products Market, by End-user, 2022 - 2028 (USD Million)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
        • 10.5.3.1 Asia Pacific Microbial Therapeutic Products Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Asia Pacific Microbial Therapeutic Products Market, by Product, 2022 - 2028
      • 10.4.1 Asia Pacific Microbial Therapeutic Products Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Asia Pacific Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028
      • 10.5.1 Asia Pacific Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028 (USD Million)
    • 10.6 Asia Pacific Microbial Therapeutic Products Market, by Source, 2022 - 2028
      • 10.6.1 Asia Pacific Microbial Therapeutic Products Market, by Source, 2022 - 2028 (USD Million)
    • 10.7 Asia Pacific Microbial Therapeutic Products Market, by Application, 2022 - 2028
      • 10.7.1 Asia Pacific Microbial Therapeutic Products Market, by Application, 2022 - 2028 (USD Million)
    • 10.8 Asia Pacific Microbial Therapeutic Products Market, by End-user, 2022 - 2028
      • 10.8.1 Asia Pacific Microbial Therapeutic Products Market, by End-user, 2022 - 2028 (USD Million)
    • 10.6. Latin America
      • 10.6.4 Latin America Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
        • 10.6.4.1 Latin America Microbial Therapeutic Products Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 Latin America Microbial Therapeutic Products Market, by Product, 2022 - 2028
      • 10.4.1 Latin America Microbial Therapeutic Products Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 Latin America Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028
      • 10.5.1 Latin America Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028 (USD Million)
    • 10.6 Latin America Microbial Therapeutic Products Market, by Source, 2022 - 2028
      • 10.6.1 Latin America Microbial Therapeutic Products Market, by Source, 2022 - 2028 (USD Million)
    • 10.7 Latin America Microbial Therapeutic Products Market, by Application, 2022 - 2028
      • 10.7.1 Latin America Microbial Therapeutic Products Market, by Application, 2022 - 2028 (USD Million)
    • 10.8 Latin America Microbial Therapeutic Products Market, by End-user, 2022 - 2028
      • 10.8.1 Latin America Microbial Therapeutic Products Market, by End-user, 2022 - 2028 (USD Million)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
        • 10.7.5.1 The Middle-East and Africa Microbial Therapeutic Products Market, by Country, 2022 - 2028 (USD Million)
    • 10.4 The Middle-East and Africa Microbial Therapeutic Products Market, by Product, 2022 - 2028
      • 10.4.1 The Middle-East and Africa Microbial Therapeutic Products Market, by Product, 2022 - 2028 (USD Million)
    • 10.5 The Middle-East and Africa Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028
      • 10.5.1 The Middle-East and Africa Microbial Therapeutic Products Market, by Route of Administration, 2022 - 2028 (USD Million)
    • 10.6 The Middle-East and Africa Microbial Therapeutic Products Market, by Source, 2022 - 2028
      • 10.6.1 The Middle-East and Africa Microbial Therapeutic Products Market, by Source, 2022 - 2028 (USD Million)
    • 10.7 The Middle-East and Africa Microbial Therapeutic Products Market, by Application, 2022 - 2028
      • 10.7.1 The Middle-East and Africa Microbial Therapeutic Products Market, by Application, 2022 - 2028 (USD Million)
    • 10.8 The Middle-East and Africa Microbial Therapeutic Products Market, by End-user, 2022 - 2028
      • 10.8.1 The Middle-East and Africa Microbial Therapeutic Products Market, by End-user, 2022 - 2028 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 Amgen Inc.
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 F. Hoffmann La-Roche Ltd.
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 Mylan N.V.
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Novartis AG
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 Biocon
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Merck & Co. Inc.
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 Pfizer Inc.
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Intas Pharmaceuticals Ltd.
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Dr. Reddy's Laboratories Ltd.
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 Eli Lilly and Company
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 Sanofi S.A.
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 Boehringer Ingelheim
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 Bristol-Myers Squibb Company
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 Novo Nordisk A/S
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 Abbot Laboratories.
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Microbial Therapeutic Products Market attractiveness, By Product
  • 6. Global Microbial Therapeutic Products Market attractiveness, By Route of Administration
  • 7. Global Microbial Therapeutic Products Market attractiveness, By Source
  • 8. Global Microbial Therapeutic Products Market attractiveness, By Application
  • 9. Global Microbial Therapeutic Products Market attractiveness, By End-user
  • 10. Global Microbial Therapeutic Products Market share by Product, 2022 and 2028 (USD Million)
  • 11. Global Microbial Therapeutic Products Market by GCSF, 2022 - 2028 (USD Million)
  • 12. Global Microbial Therapeutic Products Market by Peg GCSF, 2022 - 2028 (USD Million)
  • 13. Global Microbial Therapeutic Products Market by Exenatide, 2022 - 2028 (USD Million)
  • 14. Global Microbial Therapeutic Products Market by Anti-cancer Agents, 2022 - 2028 (USD Million)
  • 15. Global Microbial Therapeutic Products Market by Immunosuppressants, 2022 - 2028 (USD Million)
  • 16. Global Microbial Therapeutic Products Market by Enzymes, 2022 - 2028 (USD Million)
  • 17. Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • 18. Global Microbial Therapeutic Products Market share by Route of Administration, 2022 and 2028 (USD Million)
  • 19. Global Microbial Therapeutic Products Market by Single-use Pre-filled Injection/Injector Pens, 2022 - 2028 (USD Million)
  • 20. Global Microbial Therapeutic Products Market by Multi-use Injectors, 2022 - 2028 (USD Million)
  • 21. Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • 22. Global Microbial Therapeutic Products Market share by Source, 2022 and 2028 (USD Million)
  • 23. Global Microbial Therapeutic Products Market by Bacteria, 2022 - 2028 (USD Million)
  • 24. Global Microbial Therapeutic Products Market by Fungi, 2022 - 2028 (USD Million)
  • 25. Global Microbial Therapeutic Products Market share by Application, 2022 and 2028 (USD Million)
  • 26. Global Microbial Therapeutic Products Market by Metabolic Disorders, 2022 - 2028 (USD Million)
  • 27. Global Microbial Therapeutic Products Market by Hematological Disorders, 2022 - 2028 (USD Million)
  • 28. Global Microbial Therapeutic Products Market by Oncology, 2022 - 2028 (USD Million)
  • 29. Global Microbial Therapeutic Products Market by Immunological Disorders, 2022 - 2028 (USD Million)
  • 30. Global Microbial Therapeutic Products Market by Infectious Diseases, 2022 - 2028 (USD Million)
  • 31. Global Microbial Therapeutic Products Market by Allergic Diseases, 2022 - 2028 (USD Million)
  • 32. Global Microbial Therapeutic Products Market by Others, 2022 - 2028 (USD Million)
  • 33. Global Microbial Therapeutic Products Market share by End-user, 2022 and 2028 (USD Million)
  • 34. Global Microbial Therapeutic Products Market by Hospitals, 2022 - 2028 (USD Million)
  • 35. Global Microbial Therapeutic Products Market by Pharmaceuticals & Biopharmaceutical Companies, 2022 - 2028 (USD Million)
  • 36. Global Microbial Therapeutic Products Market by Research & Academic Institutions, 2022 - 2028 (USD Million)
  • 37. Global Microbial Therapeutic Products Market share, by Region, 2022 and 2028
  • 38. North America Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
  • 39. Europe Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
  • 40. Asia Pacific Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
  • 41. Latin America Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)
  • 42. The Middle-East and Africa Microbial Therapeutic Products Market, 2022 - 2028 (USD Million)

Table Of Tables

  • 1. Global Microbial Therapeutic Products Market: Snapshot
  • 2. Drivers of the Microbial Therapeutic Products Market: impact analysis
  • 3. North America Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 4. North America Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 5. North America Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 6. North America Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 7. North America Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 8. U.S. Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 9. U.S. Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 10. U.S. Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 11. U.S. Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 12. U.S. Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 13. Canada Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 14. Canada Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 15. Canada Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 16. Canada Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 17. Canada Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 18. Europe Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 19. Europe Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 20. Europe Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 21. Europe Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 22. Europe Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 23. Germany Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 24. Germany Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 25. Germany Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 26. Germany Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 27. Germany Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 28. France Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 29. France Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 30. France Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 31. France Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 32. France Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 33. U.K. Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 34. U.K. Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 35. U.K. Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 36. U.K. Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 37. U.K. Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 38. Italy Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 39. Italy Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 40. Italy Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 41. Italy Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 42. Italy Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 43. Spain Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 44. Spain Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 45. Spain Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 46. Spain Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 47. Spain Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 48. Rest of Europe Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 49. Rest of Europe Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 50. Rest of Europe Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 51. Rest of Europe Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 52. Rest of Europe Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 53. Asia Pacific Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 54. Asia Pacific Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 55. Asia Pacific Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 56. Asia Pacific Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 57. Asia Pacific Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 58. China Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 59. China Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 60. China Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 61. China Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 62. China Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 63. Japan Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 64. Japan Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 65. Japan Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 66. Japan Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 67. Japan Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 68. India Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 69. India Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 70. India Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 71. India Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 72. India Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 73. South Korea Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 74. South Korea Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 75. South Korea Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 76. South Korea Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 77. South Korea Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 78. South-East Asia Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 79. South-East Asia Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 80. South-East Asia Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 81. South-East Asia Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 82. South-East Asia Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 83. Rest of Asia Pacific Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 84. Rest of Asia Pacific Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 85. Rest of Asia Pacific Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 86. Rest of Asia Pacific Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 87. Rest of Asia Pacific Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 88. Latin America Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 89. Latin America Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 90. Latin America Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 91. Latin America Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 92. Latin America Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 93. Brazil Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 94. Brazil Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 95. Brazil Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 96. Brazil Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 97. Brazil Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 98. Mexico Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 99. Mexico Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 100. Mexico Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 101. Mexico Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 102. Mexico Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 103. Rest of Latin America Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 104. Rest of Latin America Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 105. Rest of Latin America Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 106. Rest of Latin America Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 107. Rest of Latin America Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 108. The Middle-East and Africa Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 109. The Middle-East and Africa Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 110. The Middle-East and Africa Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 111. The Middle-East and Africa Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 112. The Middle-East and Africa Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 113. GCC Countries Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 114. GCC Countries Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 115. GCC Countries Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 116. GCC Countries Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 117. GCC Countries Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 118. South Africa Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 119. South Africa Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 120. South Africa Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 121. South Africa Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 122. South Africa Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)
  • 123. Rest of Middle-East Africa Microbial Therapeutic Products Market revenue, By Product, 2022 - 2028 (USD Million)
  • 124. Rest of Middle-East Africa Microbial Therapeutic Products Market revenue, By Route of Administration, 2022 - 2028 (USD Million)
  • 125. Rest of Middle-East Africa Microbial Therapeutic Products Market revenue, By Source, 2022 - 2028 (USD Million)
  • 126. Rest of Middle-East Africa Microbial Therapeutic Products Market revenue, By Application, 2022 - 2028 (USD Million)
  • 127. Rest of Middle-East Africa Microbial Therapeutic Products Market revenue, By End-user, 2022 - 2028 (USD Million)

Methodology

Choose License Type

  • zion payment modes

FrequentlyAsked Questions

According to analysts, the growing demand for healthcare nutrients such as vitamins, coupled with the increasing demand for diagnostic microbiology products, is expected to drive the market in the forecast years. In addition, the rise of diseases such as cancer is expected to boost the industry in the coming years. Other factors expected to drive market growth during the estimated period include enzyme production for end-use industries such as food preservation, leather, and paper. Several limitations and issues need to be overcome for the market to continue to grow.

According to a report, the global microbial therapeutic products market size was worth 63,281.50 (USD million) in 2021 and is predicted to grow to 95,502.24 (USD Million) by 2028 with a compound annual growth rate (CAGR) of about 7.10 percent.

North America is expected to be the dominant market during the forecast period due to technological advances and increased industry research and development investment. Each year, the personal care industry in the United States reaches an increasingly high level of development.

Some of the main competitors dominating the global microbial therapeutic products market include Amgen Inc., F. Hoffmann La-Roche Ltd., Mylan N.V., Novartis AG, Biocon, Merck & Co. Inc., Pfizer Inc., Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Eli Lilly and Company, Sanofi S.A., Boehringer Ingelheim, Bristol-Myers Squibb Company, Novo Nordisk A/S, and Abbot Laboratories.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed